Research programme: muscarinic receptor antagonists - Dong-A ST

Drug Profile

Research programme: muscarinic receptor antagonists - Dong-A ST

Alternative Names: DA-8010

Latest Information Update: 19 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dong-A ST
  • Class
  • Mechanism of Action Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Overactive bladder

Most Recent Events

  • 29 Jun 2016 Dong-A ST plans a phase I trial in Healthy volunteers in United Kingdom (PO) (NCT02821312)
  • 06 May 2016 Pharmacodynamics data from preclinical studies in Overactive bladder presented at the 111th Annual Meeting of the American Urological Association (AUA-2016)
  • 09 Oct 2015 Research programme: muscarinic receptor antagonists - Dong-A ST is available for licensing -
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top